MedPath

Influence of a 12-week supplementation with collagen peptides and resistance training on the intracellular signalling pathway of muscular protein biosynthesis as well as ultrastructural and functional adaptations in skeletal muscles

Not Applicable
Conditions
Effects of resistance training and collagen peptide intake on muscular adaptations in healthy volunteers
Registration Number
DRKS00027112
Lead Sponsor
Institut für Sport und Sportwissenschaft, Albert-Ludwigs-Universität Freiburg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
30
Inclusion Criteria

Male gender
- age between 18-29
- BMI 18.5 - 25
- Physically active:
- < 150 minutes/week of moderate-intensity exercise (e.g. 5 x 30 minutes/week) or < 75 minutes/higher-intensity exercise (running, cycling, playing sports).
- No regular participation in strength training during the last 12 months
- Stable weight and nutritional behaviour (mixed diet)
- Informed consent
- No contraindications to exercise according to ACSM guidelines
- Metabolically healthy

Exclusion Criteria

- Regular participation in strength and endurance training during the last 12 months.
- Malignant diseases in the past 5 years.
- Cardiac disease (e.g. chronic heart disease, arrhythmia, valvular disease, arthritis etc.). Cardiac disease (e.g. chronic heart disease, arrhythmia, heart valve disease, arthritis, etc.).
- Arterial hypertension (RRsyst > 200 mmHg and/or RRdiast > 105 mmHg) at rest.
- Presence of insulin-dependent diabetes mellitus (IDDM).
- Presence of a lipometabolic disorder.
- Regular intake of medication.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in mTOR activation / phosphprylation
Secondary Outcome Measures
NameTimeMethod
All secondary outcomes will be investigated either in the acute study (single strength training session with supplementation) or in the long-term study (12-week):<br><br>Acute study:<br>- Genome sequencing/transcriptome sequencing-.<br>- Protein activation (AKT, AMPK, FoXo, MuRF-1, MAFbx, PRAS40, ERK1/2, LCB3, LBC I/II, Antrogin-1).<br><br>Long-term study:<br>- Histological examinations (muscle fibre distribution, muscle cell nucleus density, fibroblast density, satellite cell distribution)<br>- Protein concentrations (AKT, AMPK, FoXo, MuRF-1, MAFbx, PRAS40, ERK1/2, LCB3, LBC I/II, Antrogin-1)<br>- Muscle volume (MRI)<br>- Tendon volume (MRT)<br>- Muscle strength
© Copyright 2025. All Rights Reserved by MedPath